Menu
Back to Journals » Infection and Drug Resistance » Volume 2 » default
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3369)
- Volume 16, 2023 (680)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Archive: Volume 2, 2009
Anidulafungin and its role in candida infections
Diane M Cappelletty, Rose Jung
Infection and Drug Resistance 2009, 2:51-60
Published Date: 30 June 2009
Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections
Tze Shien Lo, Stephanie M Borchardt, Justin M Welch, Melissa A Rohrich, Augusto M Alonto, Anne V Alonto
Infection and Drug Resistance 2009, 2:41-49
Published Date: 30 June 2009
Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus
William J Peppard, Anne Daniels, Lynne Fehrenbacher, Jamie Winner
Infection and Drug Resistance 2009, 2:27-40
Published Date: 8 June 2009
New approaches in the management of chronic hepatitis B: role of tenofovir
Jurriën GP Reijnders, Harry LA Janssen
Infection and Drug Resistance 2009, 2:13-26
Published Date: 24 April 2009
The determinants of the antibiotic resistance process
Beatriz Espinosa Franco, Marina Altagracia Martínez, Martha A Sánchez Rodríguez, Albert I Wertheimer
Infection and Drug Resistance 2009, 2:1-11
Published Date: 17 April 2009